Cytek® Biosciences Receives CE Marking for Series of cFluor® Reagents, TBNK Kit
Company Moves to Make Total Cell Analysis Solutions Available for Clinical Applications in the European MarketFREMONT, Calif., May 24, 2022…
Pharmaceuticals, Biotechnology and Life Sciences
Company Moves to Make Total Cell Analysis Solutions Available for Clinical Applications in the European MarketFREMONT, Calif., May 24, 2022…
Castellum, Inc. Announces Appointment of Former Congressman Jim Moran to Advisory Board Castellum, Inc. (OTC: ONOV) announces that former Virginia…
Press release FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: Eric Nys, general manager, [email protected] Purchase…
NEW YORK, May 23, 2022 (GLOBE NEWSWIRE) — Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biotechnology company using its…
NEW YORK, May 23, 2022 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal…
SOUTH SAN FRANCISCO, Calif., May 23, 2022 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company…
Interim analysis to be conducted following enrollment suspension in the double-blind, randomized, placebo-controlled clinical trial Next development steps for XOWNA®…
FORT COLLINS, Colo., May 23, 2022 (GLOBE NEWSWIRE) — Statera Biopharma (Nasdaq: STAB) (the “Company”), a biopharmaceutical company creating next-generation…
ROCKVILLE, MD, May 23, 2022 (GLOBE NEWSWIRE) — MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing…
Daix (France), Long Island City (New York, United States), May 23, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA) (the…